* Avid Bioservices Inc CDMO.OQ reported quarterly adjusted
earnings of 10 cents per share for the quarter ended in July.
The mean expectation of four analysts for the quarter was
for earnings of 4 cents per share.
* Revenue rose 21.1% to $30.75 million from a year ago;
analysts expected $27.81 million.
* Avid Bioservices Inc's reported EPS for the quarter was 10
cents.
* The mean earnings estimate of analysts had risen by
about 36.4% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Avid Bioservices Inc shares had fallen by 8.1% this
quarter and gained 104.3% so far this year.
* The company reported quarterly net income of $6.3 million.
* Wall Street's median 12-month price target for Avid
Bioservices Inc is $28.50
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated September 8 at 08:54 p.m.
All figures in US dollars unless otherwise stated